WHC is still in active development. Read this to understand our approach.
depiction of XADCESSVHJOZHK-UHFFFAOYSA-N.svg
tripsit

demerol

Verificar en tripsit

psychonaut

Pethidine

Verificar en psychonaut

isomerdesign

Meperidine

Verificar en isomerdesign

pubchem

Meperidine

Verificar en pubchem

druglab

Péthidine

Verificar en druglab

drugmap

Meperidine

Verificar en drugmap

wiki

Pethidine

Verificar en wiki

Data

InChI: InChI=1S/C15H21NO2/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3

Sinónimos: Pethidin, Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester,DEA No. 9230, Operidine EPJ I, Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate,Q55434, 4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester,Pethidine (Meperidine) 0.1 mg/ml in Methanol,Pethidine [INN], Pethidine,UNII-9E338QE28F,4-Carbethoxy-1-methyl-4-phenylpiperidine, Petydyna, Isonipecaine,Petydyna,Pipersal, Methyl phenylpiperidine carbonic acid ethyl ester,Renaudin,Pethidinum, Pipersal, Pethidineter,YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI), Petidina,Lidol (Salt/Mix),MEPERIDINE [VANDF],meperidine,Petidina, Pethidinum [INN-Latin], 1-Methyl-4-phenylisonipecotic acid, ethyl ester,SR-01000944492-1,Piridosal (Salt/Mix), Pethidine DBL,Mepridine, Piperosal,DB-053051,Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester,Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate,1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester,Dolsin (Salt/Mix),Dolantin (Salt/Mix),Pethidine DBL (TN),1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester,Dolosal (Salt/Mix),Nemerol,1-Methyl-4-phenyl-piperidine-4-carboxylic acid ethyl ester,NINDS_000983,57-42-1,Pethidineter,PETHIDINE [WHO-DD],Meperidine solution, 1 mg/mL in methanol, drug standard, Demerol,Petidina [INN-Spanish], Dolcontral, Dolosal, Meperidol,Petydyna [Polish],CHEBI:6754,4-Ethoxycarbonyl-1-methyl-4-phenyl-piperidinium, Pethidinum,ZINC1681, Pethanol,MEPERIDINE [MI],9E338QE28F, N-Methyl-4-phenyl-4-carbethoxypiperidine,1-Methyl-4-phenylisonipecotic acid, ethyl ester,Pethidine (INN), YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI),Operidine (Salt/Mix),Pethidine DBL, Isonipecain,Dolcontral (Salt/Mix),MEPERIDINE [HSDB],Petantin (Salt/Mix),C07128,Meperidol,Ethyl 1-methyl-4-phenyl-4-piperidinecarboxylate,IDI1_000983,Pethidine, 1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester,Pethanol, 1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German],1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester,SCHEMBL25431,Centralgin (Salt/Mix), Operidine EPJ-I,4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester,Ethyl 1-methyl-4-phenylisonipecotate, Ethyl 1-methyl-4-phenylisonipecotate, Demerol (TN),EINECS 200-329-1,1-Methyl-4-phenyl-piperidine-4-carboxylic acid ethyl ester(Meperidine),DTXSID9023253,N-Methyl-4-phenyl-4-carbethoxypiperidine,Pethidinum [INN-Latin],1-methyl-4-phenylisonipecotic acid ethyl ester,Piperosal,Isonipecaine, Petydyna [Polish],Demerol,Meperidine, Meperidine solution,Pethidine [INN:BAN],CHEMBL607,pethidine,L000908, Nemerol,1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German], Pethidin, Pethidine (INN),DB00454,HSDB 3116, 1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester,Phetidine,Ethyl(1-methyl-4-phenylpiperidin-4-carboxylate),DivK1c_000983,Meperidine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Lydol, 4-Carbethoxy-1-methyl-4-phenylpiperidine,Demarol, Petidina [INN-Spanish],meperidina,SR-01000944492, Pethidine DBL (TN),Lydol (Salt/Mix),Pethidine (Meperidine) 1.0 mg/ml in Methanol,Dolaren (Salt/Mix),Dispadol (Salt/Mix),KBio1_000983, Lidol,D08343, Phetidine,IDS-NP-001,GTPL7221,Methyl phenylpiperidine carbonic acid ethyl ester,BDBM50026752, Dolsin


Estimated data

Solubilidad: -2.243 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 85.6% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.